Related Experiment Video
Updated: Jul 7, 2026

14:43
Lignin Down-regulation of Zea mays via dsRNAi and Klason Lignin Analysis
Published on: July 23, 2014
Lignans from Kadsura angustifolia.
Xue-Mei Gao1, Jian-Xin Pu, Sheng-Xiong Huang
1State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650204, Yunnan, People's Republic of China.
Journal of Natural Products
|February 19, 2008
Summary
Phytochemical analysis of Kadsura angustifolia yielded 11 new lignans. One compound, Binankadsurin A, demonstrated significant anti-human immunodeficiency virus (HIV) activity, offering potential for new therapeutic strategies.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Kadsura angustifolia is a plant species known for its diverse phytochemical constituents.
- Lignans and triterpenoids are classes of natural compounds with a wide range of biological activities.
- Investigating the chemical composition of medicinal plants can lead to the discovery of novel bioactive molecules.
Purpose of the Study:
- To conduct a phytochemical investigation of Kadsura angustifolia.
- To isolate, identify, and characterize new lignans and triterpenoids from the plant.
- To evaluate the isolated lignans for their inhibitory activity against human immunodeficiency virus type 1 (HIV-1).
Main Methods:
- Extraction and isolation of compounds from Kadsura angustifolia using various chromatographic techniques.
- Structure elucidation of isolated compounds through comprehensive spectroscopic analyses (NMR, MS, etc.).
- In vitro anti-HIV-1 activity assay to determine the efficacy of lignans.
Main Results:
- Isolation and identification of 26 lignans and two triterpenoids.
- Discovery and characterization of 11 new lignans, named kadangustins A-K.
- Binankadsurin A exhibited notable anti-HIV-1 activity with an EC50 value of 3.86 microM.
Conclusions:
- Kadsura angustifolia is a rich source of structurally diverse lignans.
- The new lignans, particularly Binankadsurin A, show potential as anti-HIV agents.
- Further research into these compounds may lead to the development of novel antiviral therapies.

